• OPEN AN ACCOUNT
Indian Indices
Nifty
25,879.15 3.35
(0.01%)
Sensex
84,478.67 12.16
( 0.01%)
Bank Nifty
58,381.95 107.30
( 0.18%)
Nifty IT
36,679.50 -175.90
( -0.48%)
Global Indices
Nasdaq
48,279.16 330.20
(0.69%)
Dow Jones
6,872.70 5.09
(0.07%)
Hang Seng
51,206.70 143.39
(0.28%)
Nikkei 225
9,910.49 10.89
(0.11%)
Forex
USD-INR
88.68 0.06
(0.07%)
EUR-INR
102.52 0.03
(0.03%)
GBP-INR
116.74 0.13
(0.11%)
JPY-INR
0.58 0.00
(-0.30%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
868.316327
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
27.82
52123.9
EPS(TTM)
Face Value()
Div & Yield %
66.4
1
0.14
 

As on: Nov 13, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,876.40 29.35 42713 27.82
Stock Price Details
Open Price() 1,857.50
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,919.00
Today's Low () 1,846.15
52-Week High () 2286.15
152-Week Low () 1274.7
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.14
Eps 66.4
Book Value 868.316327
Market Cap (.Cr) 52,123.90
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE935A01035


News
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glenmark set to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial
Glenmark Pharma’s US subsidiary to launch 8.4% sodium bicarbonate injection in US market
Glenmark Pharmaceuticals to conduct board meeting
Glenmark Pharmaceuticals Ltd spurts 0.02%, rises for fifth straight session
Glenmark Pharmaceuticals Ltd up for third consecutive session
Glenmark Pharma set to launch Ropivacaine Hydrochloride Injection in US
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
Board of Glenmark Pharmaceuticals recommends interim dividend
Glenmark Pharmaceuticals Ltd - Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th September 2025
More
Corporate Details
Incoporation Year   : 1977
Chairman : Glenn Saldanha
Bussiness Group : Indian Private
Registered Office
Glenmark Pharmaceuticals Ltd
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra-400026
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40189999
Fax:91-22-40189986
Fax:91-22-66317458
E-Mail : complianceofficer@glenmarkpharma.com
URL : http://www.glenmarkpharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE Midcap
  • BSE Shariah 50
  • MIDCAP 200
  • CNX 500
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi